510(k) K210983
K210983 is an FDA 510(k) premarket notification submitted by Becton, Dickinson And Company for the device "BD Epilor Syringe". The FDA issued a decision of Substantially Equivalent on May 19, 2022. The device falls under product code CAZ (Anesthesia Conduction Kit), a Class II device regulated under 21 CFR 868.5140. Becton, Dickinson And Company has 330 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 19, 2022
- Date Received
- Apr 1, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Anesthesia Conduction Kit
- Device Class
- Class II
- Regulation Number
- 868.5140
- Review Panel
- AN
- Submission Type
- 510(k)
This product code has been established in accordance with the May 20, 1997, Guidance entitled, Convenience Kits Interim Regulatory Guidance, found at www.fda.gov/cdrh/ode/convkit.html. This type of convenience kit, as listed in the guidance above, is under enforcement discretion, and does not require a premarket notification (510(k)) to market if it meets all criteria in the guidance.
Need the full FDA record for Becton, Dickinson And Company? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.